Description
The discovery of insulin 100 years ago was a true breakthrough and lifesaver in the treatment of people with diabetes. However, despite being around for a century, insulin and other means of treatment, often deployed in a one-size-fits-all manner, still fail to take most people to a level of control that normalizes morbidity and mortality. Precision medicine, the tailoring of disease prevention and treatment strategies based on an individual’s genetics and other biomarkers, lifestyle and environment, aims at doing just that, by helping optimise medical decisions.This two-day symposium on the future of precision medicine will feature lectures and panel discussions on precision diagnostics, precision prevention, pediatric precision medicine, clinical implementation, health disparities, the power of big data, patient perspectives, and policy and implementation, with a focus on the opportunities and barriers for the implementation of precision medicine in research and practice.
The symposium will also celebrate the winner of the EFSD and Novo Nordisk Foundation Precision Diabetes Medicine Award. The award honours innovative research in both clinical and basic science that are likely to minimise the future burden of diabetes and other chronic disease.
| Period | 22 Nov 2021 → 23 Nov 2021 |
|---|---|
| Event type | Seminar |
| Location | Hellerup, DenmarkShow on map |
| Degree of Recognition | International |